Author (Corporate) | European Medicines Agency |
---|---|
Series Title | Press Release |
Series Details | EMA/65929/2013-corr (31.01.13) |
Publication Date | 31/01/2013 |
Content Type | News |
The French medicines agency (ANSM), on 31 January 2013, announced its plan to suspend the marketing authorisation for Diane 35 and its generics for acne treatment in France within three months. The Agency considered that Diane 35 and its generics carried a risk of thromboembolism. |
|
Source Link | Link to Main Source http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/01/news_detail_001703.jsp&mid=WC0b01ac058004d5c1 |
Related Links |
|
Subject Categories | Health |
Countries / Regions | Europe, France |